Compared with healthy controls, patients with COPD had lower PGC-1α mRNA expression in skeletal muscle, accompanied by reduced TFAM protein levels, which may be linked to decreased muscle oxidation capacity in COPD (Remels et al., 2007). Here, TFAM is linked to chronic obstructive pulmonary disease.